SG10201608055XA - A method for selection of agents influencing intestinal motility disorders and pain - Google Patents

A method for selection of agents influencing intestinal motility disorders and pain

Info

Publication number
SG10201608055XA
SG10201608055XA SG10201608055XA SG10201608055XA SG10201608055XA SG 10201608055X A SG10201608055X A SG 10201608055XA SG 10201608055X A SG10201608055X A SG 10201608055XA SG 10201608055X A SG10201608055X A SG 10201608055XA SG 10201608055X A SG10201608055X A SG 10201608055XA
Authority
SG
Singapore
Prior art keywords
pain
selection
intestinal motility
motility disorders
agents influencing
Prior art date
Application number
SG10201608055XA
Inventor
Eamonn Connolly
Wolfgang Kunze
John Bienenstock
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49115523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201608055X(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of SG10201608055XA publication Critical patent/SG10201608055XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/10Segmentation; Edge detection
    • G06T7/13Edge detection
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/30Subject of image; Context of image processing
    • G06T2207/30004Biomedical image processing
    • G06T2207/30092Stomach; Gastric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Quality & Reliability (AREA)
SG10201608055XA 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain SG10201608055XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261696277P 2012-09-03 2012-09-03

Publications (1)

Publication Number Publication Date
SG10201608055XA true SG10201608055XA (en) 2016-11-29

Family

ID=49115523

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10202101556WA SG10202101556WA (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain
SG10201608055XA SG10201608055XA (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain
SG11201501297TA SG11201501297TA (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10202101556WA SG10202101556WA (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201501297TA SG11201501297TA (en) 2012-09-03 2013-09-03 A method for selection of agents influencing intestinal motility disorders and pain

Country Status (27)

Country Link
US (5) US9555065B2 (en)
EP (2) EP2893045B1 (en)
JP (3) JP6259458B2 (en)
KR (1) KR102293438B1 (en)
CN (4) CN108904545A (en)
AU (1) AU2013308299B2 (en)
CA (1) CA2883440A1 (en)
CL (2) CL2015000490A1 (en)
CO (1) CO7350654A2 (en)
DK (1) DK2893045T3 (en)
ES (1) ES2681974T3 (en)
GE (1) GEP201706775B (en)
HK (3) HK1211848A1 (en)
HR (1) HRP20181033T1 (en)
IL (2) IL237397B (en)
IN (1) IN2015DN01572A (en)
LT (1) LT2893045T (en)
MX (2) MX362495B (en)
MY (2) MY182358A (en)
NZ (1) NZ705358A (en)
PH (1) PH12015500452A1 (en)
RU (1) RU2701348C2 (en)
SG (3) SG10202101556WA (en)
SI (1) SI2893045T1 (en)
UA (2) UA118339C2 (en)
WO (1) WO2014033330A1 (en)
ZA (1) ZA201501472B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013109251A (en) 2010-08-04 2014-09-10 Томас Джулиус БОРОДИ COMPOSITIONS FOR TRANSPLANTATION OF FEKAL FLORA AND METHODS FOR THEIR RECEIVING AND APPLICATION AND DEVICES FOR THEIR DELIVERY
CN108094541A (en) * 2018-01-11 2018-06-01 黑龙江完达山林海液奶有限公司 A kind of flavored fermented milk for having the function of that health care is prebiotic and preparation method thereof
HUE059963T2 (en) 2018-07-24 2023-01-28 Biogaia Ab Selection and use of melatonin supporting bacteria to reduce infantile colic
CN113966284A (en) * 2019-06-05 2022-01-21 Avl动力工程公司 Vehicle axle assembly
CN110186922B (en) * 2019-06-25 2021-07-23 西安交通大学医学院第一附属医院 Experimental device and method for monitoring colon transitional compound movement
US11843097B2 (en) 2019-09-10 2023-12-12 Avl Powertrain Engineering, Inc. Power supply control systems and methods
CN112710823B (en) * 2020-12-17 2024-03-29 中国科学院深圳先进技术研究院 In-vitro detection system for intestinal motility compound motion and application thereof
CN114342878B (en) * 2022-01-10 2022-09-30 南京鼓楼医院 Establishment method of slow transmission type constipation animal model
CN117384804A (en) * 2023-12-12 2024-01-12 北京三元食品股份有限公司 Lactobacillus gasseri B1-26 and application thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5438989A (en) * 1990-08-10 1995-08-08 Hochman; Darryl Solid tumor, cortical function, and nerve tissue imaging methods and device
PL200132B1 (en) * 1998-08-21 2008-12-31 Novartis Ag Application of 3-(5-methoxy-1H-indole-3-methylene)-N-pentyl carbazyl imidoamide
EP1196164A2 (en) * 1999-07-06 2002-04-17 Enpharma L.P. Methods and compositions for regulating gut motility and food intake
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
CN1663573B (en) * 2004-03-04 2010-04-28 青岛东海药业有限公司 A stable and safe microecological formulation, its preparation and usage
US20090233888A1 (en) * 2005-03-23 2009-09-17 Usc Stevens, University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
JP5036020B2 (en) * 2005-11-30 2012-09-26 雪印メグミルク株式会社 Perirenal fat accumulation inhibitor
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
JP5019563B2 (en) * 2006-06-16 2012-09-05 旭化成ケミカルズ株式会社 Intestinal bacteria activator
EP2200443B2 (en) * 2007-09-17 2021-06-30 Cornell University Branched chain fatty acids for prevention or treatment of gastrointestinal disorders
MX2012001362A (en) * 2009-07-31 2012-02-22 Nestec Sa Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients.
US20110110905A1 (en) * 2009-11-06 2011-05-12 Ritchie Jennifer A Infant Colic Supplement
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
US20120034198A1 (en) * 2010-08-04 2012-02-09 Microbios, Inc. Carriers for storage and delivery of biologics
CN102304489B (en) * 2011-09-23 2013-06-12 北京龙科方舟生物工程技术有限公司 Lactobacillus reuteri strain and application thereof

Also Published As

Publication number Publication date
US10174388B2 (en) 2019-01-08
MX362495B (en) 2019-01-21
HK1258774A1 (en) 2019-11-22
LT2893045T (en) 2018-07-25
GEP201706775B (en) 2017-11-27
UA126374C2 (en) 2022-09-28
AU2013308299A1 (en) 2015-03-26
CN108904545A (en) 2018-11-30
HRP20181033T1 (en) 2018-08-24
EP2893045B1 (en) 2018-05-16
SG10202101556WA (en) 2021-03-30
JP2018090616A (en) 2018-06-14
US20180023150A1 (en) 2018-01-25
US9816150B2 (en) 2017-11-14
KR20150048201A (en) 2015-05-06
CA2883440A1 (en) 2014-03-06
DK2893045T3 (en) 2018-07-30
AU2013308299B2 (en) 2019-04-18
EP2893045A1 (en) 2015-07-15
US20170114422A1 (en) 2017-04-27
US9555065B2 (en) 2017-01-31
JP2015529329A (en) 2015-10-05
IN2015DN01572A (en) 2015-07-03
MY195532A (en) 2023-01-31
CO7350654A2 (en) 2015-08-10
IL259652A (en) 2018-07-31
JP6476328B2 (en) 2019-02-27
HK1258778A1 (en) 2019-11-22
US20150231186A1 (en) 2015-08-20
CN108753645A (en) 2018-11-06
UA118339C2 (en) 2019-01-10
WO2014033330A1 (en) 2014-03-06
CN104918640A (en) 2015-09-16
US20190112676A1 (en) 2019-04-18
IL237397B (en) 2018-10-31
CL2017002826A1 (en) 2018-04-06
EP3369808A1 (en) 2018-09-05
RU2701348C2 (en) 2019-09-26
SG11201501297TA (en) 2015-03-30
CL2015000490A1 (en) 2015-05-29
SI2893045T1 (en) 2018-08-31
CN104918640B (en) 2019-03-19
MY182358A (en) 2021-01-20
KR102293438B1 (en) 2021-08-25
JP6259458B2 (en) 2018-01-10
PH12015500452A1 (en) 2015-04-20
MX2018013097A (en) 2020-09-02
CN108753645B (en) 2019-10-22
ES2681974T3 (en) 2018-09-17
JP2018029588A (en) 2018-03-01
MX2015002792A (en) 2015-05-07
RU2015112102A (en) 2016-10-20
JP6322326B2 (en) 2018-05-09
HK1211848A1 (en) 2016-06-03
NZ705358A (en) 2018-09-28
IL259652B (en) 2020-03-31
US20220306984A1 (en) 2022-09-29
ZA201501472B (en) 2016-06-29
IL237397A0 (en) 2015-04-30
CN109966511A (en) 2019-07-05

Similar Documents

Publication Publication Date Title
HK1258778A1 (en) A method for selection of agents influencing intestinal motility disorders and pain
HK1205915A1 (en) Multi-frame prosthetic valve apparatus and methods
GB201219729D0 (en) Device and method of forming a device
EP2908722A4 (en) A wearable apparatus and associated methods
EP2908721A4 (en) A wearable apparatus and associated methods
PL2730266T3 (en) Gait training apparatus
GB201205451D0 (en) Method for stimulating muscles of a subject and apparatus for performing the same
EP2813267A4 (en) Walking training apparatus
EP2844271A4 (en) A method of treatment and agents useful for same
GB2500641B (en) Apparatus for stimulating muscles of a subject
IL230433A0 (en) Methods of treating pain
EP2803344A4 (en) Therapeutic exercise method and therapeutic exercise apparatus
EP2587712A4 (en) Heartbeat synchronization method and device
HK1216504A1 (en) Method for treatment of diseases
EP2694168A4 (en) Health aid and method for treating pain
HK1201741A1 (en) Method of prevention of neurological diseases
EP2825113A4 (en) Method and device for ameliorating joint conditions and diseases
PL2665602T3 (en) Ultra-resilient pad and method of making thereof
EP2852840A4 (en) Selection method for therapeutic agents
EP2809173A4 (en) Chocolate production method and apparatus
TWM432421U (en) Brain wave interaction device for rehabilitation of dementia
EP2911662A4 (en) Method of treatment of disease
PL3041506T3 (en) A method of treatment
GB2500727B (en) Lighting apparatus and a method of lighting
GB201221032D0 (en) Method of treatment